LACY BOUDREAUX: Open Payments
NPI 1538543509 · DONALDSONVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,599 in 88 payments from 18 companies in 2025. Trend: 2023 $1,443 · 2024 $1,209 · 2025 $1,599
Food & beverage: $1,599
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $414 |
| Lilly USA, LLC | 15 | $240 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $140 |
| Exact Sciences Corporation | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Novo Nordisk Inc | 5 | $80 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Abbott Laboratories | 2 | $57 |
| Axsome Therapeutics, Inc. | 2 | $56 |
Products named: JARDIANCE, MOUNJARO, VRAYLAR, QULIPTA, REXULTI, CAPLYTA, LINZESS, The Cologuard Plus Collection Kit.
Industry payments across LA — which companies pay providers there.
